Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2025)

China Pharma Holdings' Depreciation and Depletion history spans 12 years, with the latest figure at $59927.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 80.53% year-over-year to $59927.0; the TTM value through Dec 2025 reached $553107.0, down 73.34%, while the annual FY2025 figure was $652026.0, 69.96% down from the prior year.
  • Depreciation and Depletion reached $59927.0 in Q4 2025 per CPHI's latest filing, down from $158076.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $966956.0 in Q3 2021 to a low of $59927.0 in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $542053.0, with a median of $635149.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: skyrocketed 45.54% in 2021, then tumbled 80.53% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $701100.0 in 2021, then fell by 10.03% to $630781.0 in 2022, then rose by 0.44% to $633577.0 in 2023, then crashed by 51.43% to $307741.0 in 2024, then plummeted by 80.53% to $59927.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Depreciation and Depletion are $59927.0 (Q4 2025), $158076.0 (Q3 2025), and $163503.0 (Q2 2025).